Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
500 participants
OBSERVATIONAL
2021-02-15
2021-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Burden, Mortality and Supply Costs in Intensive Care Unit Patients
NCT04094428
COVID-19 Follow up Intensive Care Studies
NCT04460170
Clinical Features of Severe Patients With COVID-19
NCT04450017
Factors Associated With Early Readmission in Critical Care
NCT07182916
Clinical Characteristics of Critically Ill Patients With COVID-19
NCT04413435
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Before SARS-Cov2
Before SARS-Cov2
Cost
ICU cost
After SARS-Cov2
After SARS-Cov2
Cost
ICU cost
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cost
ICU cost
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* All patients in intensive care unit in last three months of 2019
* All SARS-Cov2 patients in intensive care unit in last three months of 2020
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kocaeli Derince Education and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Merve Yazici Kara
MD
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
References
Explore related publications, articles, or registry entries linked to this study.
Khan AA, AlRuthia Y, Balkhi B, Alghadeer SM, Temsah MH, Althunayyan SM, Alsofayan YM. Erratum: Khan, A.A., et al. Survival and Estimation of Direct Medical Costs of Hospitalized COVID-19 Patients in the Kingdom of Saudi Arabia (Short Title: COVID-19 Survival and Cost in Saudi Arabia). Int. J. Environ. Res. Public Health 2020, 17, 7458. Int J Environ Res Public Health. 2020 Dec 17;17(24):9458. doi: 10.3390/ijerph17249458.
Related Links
Access external resources that provide additional context or updates about the study.
WHO Coronavirus Disease (COVID-19) Dashboard
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Ilke-ICU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.